Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors

ID:am030003M0035233ridk35256📫 -页
Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors
⚠ 举报QQ邮箱: 361755509@qq.com⚠ 版权申诉QQ邮箱: 361755509@qq.com

内容摘要

Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors

海外数据平台所有内容均是公开网络、AI代理代查、客户上传分享、合作方,仅供网友学习交流,请勿商用!

海外数据(小程序)

微信小程序

请使用微信扫码打开小程序